-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Reiterates Buy on Coya Therapeutics, Maintains $16 Price Target

Benzinga·09/15/2026 16:11:59
Listen to the news
BTIG analyst Thomas Shrader reiterates Coya Therapeutics (NASDAQ:COYA) with a Buy and maintains $16 price target.